Keurig Dr Pepper (KDP)
(Delayed Data from NSDQ)
$32.83 USD
-0.15 (-0.45%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $32.89 +0.06 (0.18%) 6:42 PM ET
4-Sell of 5 4
D Value F Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
KDP 32.83 -0.15(-0.45%)
Will KDP be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for KDP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KDP
Keurig Dr Pepper (KDP) to Report Q2 Earnings: What's in Store?
Investing in Coca-Cola (KO) Before Q2 Earnings: Smart Move?
KDP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Keurig Dr Pepper, Inc (KDP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Is Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) a Strong ETF Right Now?
The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Eaton, Palo Alto, Keurig Dr Pepper and Yum! Brands
Other News for KDP
Keurig Dr Pepper price target lowered by $1 at Barclays, here's why
Oakmark Equity And Income Fund: Q2 2024 Commentary
Barclays Keeps Their Buy Rating on Keurig Dr Pepper (KDP)
Looking Into Keurig Dr Pepper's Recent Short Interest
Keurig Dr Pepper to Report Second Quarter 2024 Results and Host Conference Call